Literature DB >> 8531012

Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

J Terryberry1, M Sutjita, Y Shoenfeld, B Gilburd, D Tanne, M Lorber, I Alosachie, N Barka, H C Lin, P Youinou.   

Abstract

We surveyed the frequency of reported infections and target autoantigens in 56 Guillain Barré syndrome (GBS) patients by detecting antibodies to myelin and microbes. Sulfatide (43%), cardiolipin (48%), GD1a (15%), SGPG (11%), and GM3 (11%) antibodies were the most frequently detected heterogenous autoantibodies. A wide spectrum of antimicrobial IgG and IgM antibodies were also detected; mumps-specific IgG (66%), adenovirus-specific IgG (52%), varicella-zoster virus-specific IgG (46%), and S. pneumoniae serotype 7-specific IgG (45%) were the most prevalent. Our results indicate that polyclonal expansion of physiologic and pathologic antibodies and/or molecular mimicry likely occurs following infection and is related to other autoimmune factors in the etiology of GBS. Although no single definitive myelin-specific autoantibody was identified, our results suggest a unique pattern of reactivity against autoantigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531012      PMCID: PMC7167197          DOI: 10.1002/jcla.1860090506

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  131 in total

1.  Guillain-Barré syndrome associated with rubella.

Authors:  M C Atkins; T F Esmonde
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 2.  Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome.

Authors:  R H Quarles; A A Ilyas; H J Willison
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.

Authors:  M Schmied; H Breitschopf; R Gold; H Zischler; G Rothe; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

4.  Varicella-zoster virus and facial palsy.

Authors:  R D Leeming
Journal:  J Laryngol Otol       Date:  1976-04       Impact factor: 1.469

Review 5.  Gangliosides and bacterial toxins in Guillain-Barré syndrome.

Authors:  H J Willison; P G Kennedy
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

6.  Lumbosacral radiculoplexopathy as a manifestation of Epstein-Barr virus infection.

Authors:  K R Sharma; S Sriram; T Fries; H J Bevan; W G Bradley
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

7.  A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE).

Authors:  A Khalili; R C Cooper
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

8.  Anti-GM1 IgA antibodies in Guillain-Barré syndrome.

Authors:  A A Ilyas; F A Mithen; Z W Chen; S D Cook
Journal:  J Neuroimmunol       Date:  1992-01       Impact factor: 3.478

Review 9.  An approach to searching protein sequences for superfamily relationships or chance similarities relevant to the molecular mimicry hypothesis: application to the basic proteins of myelin.

Authors:  M J Weise; P R Carnegie
Journal:  J Neurochem       Date:  1988-10       Impact factor: 5.372

10.  Elevated levels of antibodies against sulphatide are present in all chronic chagasic and dilated cardiomyopathy sera.

Authors:  J L Avila; M Rojas; H Carrasco
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more
  5 in total

Review 1.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 2.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens.

Authors:  I J Alosachie; J W Terryberry; D Mevorach; Y Chapman; M Lorber; D Torre; P Youinou; J B Peter; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

5.  Differential binding patterns of anti-sulfatide antibodies to glial membranes.

Authors:  Gavin R Meehan; Rhona McGonigal; Madeleine E Cunningham; Yuzhong Wang; Jennifer A Barrie; Susan K Halstead; Dawn Gourlay; Denggao Yao; Hugh J Willison
Journal:  J Neuroimmunol       Date:  2018-07-09       Impact factor: 3.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.